Esiaka Darlingtina K, Nwakasi Candidus, Nnamele Vincent U, Idu Amarachi O, Egwuonwu Joshua, Mahmoud Kafayat O
Department of Family Medicine and Community Health, Rutgers University, New Brunswick, New Jersey, USA.
Department of Health Sciences, Providence College, Providence, Rhode Island, USA.
Psychooncology. 2023 Jul;32(7):991-1000. doi: 10.1002/pon.6167. Epub 2023 May 19.
With advancements in medicine and technology, more people are surviving cancers. However, cancer mortality in Nigeria remains high. The yearly estimate is 72,000 cancer-related deaths, making cancer one of the leading causes of death in Nigeria. The current study aimed to identify and synthesize factors that facilitate or hinder cancer survivorship in Nigeria and add to our understanding of the patterns of cancer survivorship in LMICs, such as Nigeria.
Following preferred reporting items for systematic reviews and meta-analyses guidelines, a systematic review was conducted across PubMed, Cochrane, and Scopus databases. We identified 31 peer-reviewed studies that examined cancer treatment, management, care, and survivorship in Nigeria.
Eight themes emerged from 31 peer-reviewed studies that examined the factors that facilitate or hinder cancer survivorship among Nigerians. They include themes such as self-care and management, treatment options, availability of pseudo-doctors/pharmacists, and the desire to live. The themes were further grouped into three overarching themes: psychosocial, economic, and health care.
Cancer survivors in Nigeria face many unique experiences that impact their health outcomes and chances of survivorship. Therefore, understanding cancer survivorship in Nigeria must involve studies on diagnosis, treatment, remission, surveillance, after-cancer care, and end-of-life. With enhanced support, cancer survivors will have improved health, thereby reducing the cancer mortality rate in Nigeria.
随着医学和技术的进步，越来越多的癌症患者得以存活。然而，尼日利亚的癌症死亡率仍然很高。据估计，每年有72000人死于癌症相关疾病，这使得癌症成为尼日利亚主要的死因之一。本研究旨在识别并综合促进或阻碍尼日利亚癌症幸存者生存的因素，增进我们对尼日利亚等低收入和中等收入国家（LMICs）癌症幸存者模式的理解。
按照系统评价和荟萃分析的首选报告项目指南，在PubMed、Cochrane和Scopus数据库中进行了系统评价。我们确定了31项经同行评审的研究，这些研究探讨了尼日利亚的癌症治疗、管理、护理和幸存者情况。
31项经同行评审的研究中出现了八个主题，这些研究探讨了促进或阻碍尼日利亚人癌症幸存者生存的因素。它们包括自我护理和管理、治疗选择、伪医生/药剂师的可及性以及生存愿望等主题。这些主题进一步归纳为三个总体主题：心理社会、经济和医疗保健。
尼日利亚的癌症幸存者面临许多独特的经历，这些经历会影响他们的健康状况和生存机会。因此，了解尼日利亚的癌症幸存者情况必须涉及对诊断、治疗、缓解、监测、癌症后护理和临终关怀的研究。通过加强支持，癌症幸存者的健康状况将得到改善，从而降低尼日利亚的癌症死亡率。
